	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Agios Pharmaceuticals	USD -125.8M	20.45M	2025-06
Alnylam Pharmaceuticals	USD 381.78M	362.95M	2025-09
Amgen	USD 5.91B	2.31B	2025-09
Arrowhead Research	USD 64.2M	223.53M	2025-09
Astellas Pharma	JPY 183.68B	31.98B	2025-12
AstraZeneca	USD 4.96B	127M	2025-06
Bayer	EUR 1.51B	1.28B	2025-09
Biogen	USD 573.2M	253.7M	2025-12
BioMarin Pharmaceutical	USD 295.45M	49.49M	2025-06
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Daiichi Sankyo	JPY 101.6B	22.81B	2025-03
Eli Lilly	USD 7.88B	378.1M	2025-09
Exelixis	USD 248.93M	28.02M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Incyte	USD 581.52M	358.87M	2025-06
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Moderna	USD -208M	552M	2025-09
Novartis	USD 5.88B	290M	2025-09
Novartis	USD 5.84B	235M	2025-09
Pfizer	USD 6.08B	351M	2025-09
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09

Agios Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.